Clinical Trials

Showing trials with last updates posted in 2021.

NCT03881735 | WITHDRAWN | PHASE2
0 participants

Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2021-03-10
Start Date:
2019-12-02
Completion:
2021-11-19
Conditions
  • Blasts Under 5 Percent of Peripheral Blood White Cells
  • Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level
  • IDH2 Gene Mutation
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT03876236 | COMPLETED
10 participants

Reproducibility of Brain MRI

Study Type:
OBSERVATIONAL
Last Updated:
2021-03-10
Start Date:
2019-02-04
Completion:
2019-05-04
Conditions
  • Reproducibility of Results
No Results Yet
NCT03434938 | UNKNOWN | NA
272 participants

IMAGINE Study Protocol

Study Type:
INTERVENTIONAL
Last Updated:
2021-03-10
Start Date:
2018-06-19
Completion:
2021-06-30
Conditions
  • Patients (>=60 Years Old) Suffering From Mild-moderate Stroke (Ischemic or Hemorrhagic, Stroke Severity Assessed by NIHSS <16 Points)
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page